Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B (L-AmpB-LRC) in a child. 1995

S C Karande, and K F Boby, and K R Lahiri, and M K Jain, and N A Kshirsagar, and P C Gokhale, and S K Pandya
Department of Pediatrics, Seth G S Medical College, Parel, Bombay, India.

UI MeSH Term Description Entries
D007893 Leishmania donovani A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors. Leishmania (Leishmania) donovani,Leishmania leishmania donovani,Leishmania donovanus,Leishmania leishmania donovanus,donovani, Leishmania leishmania,donovanus, Leishmania,donovanus, Leishmania leishmania,leishmania donovanus, Leishmania
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone

Related Publications

S C Karande, and K F Boby, and K R Lahiri, and M K Jain, and N A Kshirsagar, and P C Gokhale, and S K Pandya
March 1996, The Journal of the Association of Physicians of India,
S C Karande, and K F Boby, and K R Lahiri, and M K Jain, and N A Kshirsagar, and P C Gokhale, and S K Pandya
April 1994, The Journal of antimicrobial chemotherapy,
S C Karande, and K F Boby, and K R Lahiri, and M K Jain, and N A Kshirsagar, and P C Gokhale, and S K Pandya
January 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene,
S C Karande, and K F Boby, and K R Lahiri, and M K Jain, and N A Kshirsagar, and P C Gokhale, and S K Pandya
June 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
S C Karande, and K F Boby, and K R Lahiri, and M K Jain, and N A Kshirsagar, and P C Gokhale, and S K Pandya
October 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
S C Karande, and K F Boby, and K R Lahiri, and M K Jain, and N A Kshirsagar, and P C Gokhale, and S K Pandya
January 2006, Acta bio-medica : Atenei Parmensis,
S C Karande, and K F Boby, and K R Lahiri, and M K Jain, and N A Kshirsagar, and P C Gokhale, and S K Pandya
January 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene,
S C Karande, and K F Boby, and K R Lahiri, and M K Jain, and N A Kshirsagar, and P C Gokhale, and S K Pandya
January 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene,
S C Karande, and K F Boby, and K R Lahiri, and M K Jain, and N A Kshirsagar, and P C Gokhale, and S K Pandya
May 1991, Lancet (London, England),
S C Karande, and K F Boby, and K R Lahiri, and M K Jain, and N A Kshirsagar, and P C Gokhale, and S K Pandya
January 2016, PLoS neglected tropical diseases,
Copied contents to your clipboard!